Group Insurance Commission warns GLP‑1 spending risks a $77M shortfall; staff to return with options in October
At its September meeting, the Group Insurance Commission said rising use of GLP‑1 weight‑loss drugs was a major driver of FY25 deficits and a projected FY26 budget gap of about $77 million. Commissioners asked staff for specific savings plans and said any midyear coverage change would require legislative authority; staff will return in October.
The full story
Valerie Sullivan, chair of the Group Insurance Commission, on Tuesday presided over a wide-ranging discussion of prescription drug spending after staff presented data showing a steep rise in GLP‑1 use and significant budget pressure.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in